Our Adaptive Delivery process draws on our customized approach to study design and conduct, especially for novel therapies.
Adaptive Delivery: our exclusive methodology for clinical trials
Expect the unexpected
Adaptive Delivery is our exclusive methodology for running clinical trials. This systematic strategy unites your team and ours to focus on your molecule and established endpoints, and to coordinate staged feedback and updates throughout the trial. Leading the process is a single, highly accountable Premier Research account executive who maintains total project oversight, allowing you to remain focused on the science.
While every trial is different, all are stunningly complex and expensive to execute. Adaptive Delivery orchestrates the many pieces to make things happen when they’re supposed to happen, and devise effective solutions when things change. And things always change.
What’s more, in the biotech space, we’ve seen that customers can regularly face situations outside of their control, from pressing FDA inquiries to emergency board meetings to ongoing discussions with potential collaborators and new investors. Adaptive Delivery can accommodate all of these potential circumstances.
Innovations in rare oncology design
A rare cancer is often defined as one with an incidence of fewer than 15 per 100,000. The patient populations of these conditions are so small that traditional clinical trial design strategies can be unfeasible.